Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 893Unknown 280Recruiting 196Terminated 191Active not recruiting 93Withdrawn 66Not yet recruiting 60Enrolling by invitation 6Suspended 5

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5Observational 2

Sponsor

Cancer Type

Gastrointestinal 5Genitourinary 1CNS 1Breast 1

Conditions

Neoplasms 35Breast Neoplasms 30Prostatic Neoplasms 22Leukemia, Myeloid, Acute 20Colorectal Neoplasms 20Melanoma 17Pancreatic Neoplasms 16Glioblastoma 16Carcinoma, Non-Small-Cell Lung 16Neoplasm Metastasis 15Lung Neoplasms 13Brain Neoplasms 13Glioma 12Stomach Neoplasms 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Myelodysplastic Syndromes 11Carcinoma, Hepatocellular 11Ovarian Neoplasms 10Multiple Myeloma 9Head and Neck Neoplasms 9Triple Negative Breast Neoplasms 8Lymphoma 8Carcinoma, Renal Cell 8Leukemia 7Sarcoma 6Rectal Neoplasms 6Hematologic Neoplasms 6Esophageal Neoplasms 6Uterine Cervical Neoplasms 5Recurrence 5

Interventions

tucatinib 1trifluridine tipiracil drug combination 1Trastuzumab 1Leucovorin 1Irinotecan 1Fluorouracil 1Capecitabine 1Anticoagulants 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Suspended × Interventional × Colonic Neoplasms × Clear all
NCT06281925 2026-03-06

Cryotherapy & Oxaliplatin

NYU Langone Health

Phase NA Suspended
40 enrolled
Gastrointestinal

Colonic Neoplasms, Peripheral Nervous System Diseases

NCT05062889 2026-02-03

ERASE-CRC

Gruppo Oncologico del Nord-Ovest

Phase 2 Suspended
477 enrolled
Gastrointestinal

Colonic Neoplasms

NCT01477866 2017-12-12

CITOGENEX PA

University of Palermo

Phase NA Suspended
250 enrolled
Gastrointestinal

Colonic Neoplasms

NCT00909558 2010-02-24

Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer

Envita Medical Center, Inc.

Phase 1 Suspended
24 enrolled
BreastCNSGastrointestinalGenitourinary

Breast Neoplasms, Colonic Neoplasms, Glioma, Liver Neoplasms, Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT00443573 2008-05-07

Safety Study of Recombinant NAPc2 to Prevent Tumor Progression and Metastases in Metastatic Colon Cancer

ARCA Biopharma, Inc.

Phase 1/2 Suspended
100 enrolled
Gastrointestinal

Adenocarcinoma, Colonic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡